B of A Securities Maintains Buy on CG Oncology, Maintains $65 Price Target

Benzinga · 10/08 15:41
B of A Securities analyst Charlie Yang maintains CG Oncology (NASDAQ:CGON) with a Buy and maintains $65 price target.